Current medical research and opinionHumansPercutaneous Coronary InterventionMaleFemaleMiddle Aged
Cardiometabolic index as a novel prognostic biomarker for cardiovascular events in post-percutaneous coronary intervention patients with ST-segment elevation myocardial infarction: two-center retrospective study.
Liu Yehong, Liu Yan, Chen Ke, Liu Longqun, Gangyong Wu, Zong Gangjun
Published: 202510.1080/03007995.2025.2605695
Abstract
BACKGROUND: The Cardiometabolic Index (CMI) is a recognized metabolic marker, but its predictive efficacy for major adverse cardiovascular events (MACEs) in patients with ST-segment elevation myocardial infarction (STEMI) remains uncertain. The prima…
Preview only. Read the full abstract at the source